Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Reducing Failure-to-Initiate ART Among People Who Inject Drugs: the IMAT Strategy

NCT02167425 is registered in ClinicalTrials.gov with Pangaea Global AIDS Foundation as lead sponsor.

NCT NCT02167425
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02167425 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Reducing Failure-to-Initiate ART Among People Who Inject Drugs: the IMAT Strategy
Lead sponsor
Pangaea Global AIDS Foundation
Phase
Observational
Overall status
Unknown status
Start date
February 28, 2015
Completion date
March 31, 2017
Enrollment
800 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

hiv, opioid dependence